New combo therapy tested for Tough-to-Treat sarcoma
NCT ID NCT06528769
Summary
This study is testing whether combining two drugs, ATRA and cemiplimab, can help control advanced leiomyosarcoma, a type of cancer, in patients whose disease has worsened despite standard treatments. It will enroll 16 adults to see if the combination can shrink tumors or stop them from growing. The main goal is to measure how many patients respond to the treatment and to check its safety.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LEIOMYOSARCOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Ohio State University Comprehensive Cancer Center
RECRUITINGColumbus, Ohio, 43210, United States
Contact Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.